Laird Norton Wetherby Wealth Management’s Genomic Health, Inc. GHDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-9,219
| Closed | -$296K | – | 679 |
|
|
2017
Q3 | $296K | Buy |
9,219
+307
| +3% | +$9.86K | 0.04% | 462 |
|
|
2017
Q2 | $290K | Buy |
8,912
+317
| +4% | +$10.3K | 0.05% | 442 |
|
|
2017
Q1 | $271K | Buy |
8,595
+340
| +4% | +$10.7K | 0.05% | 453 |
|
|
2016
Q4 | $243K | Buy |
8,255
+345
| +4% | +$10.2K | 0.05% | 459 |
|
|
2016
Q3 | $229K | Buy |
+7,910
| New | +$229K | 0.05% | 461 |
|
|
2016
Q1 | – | Sell |
-6,819
| Closed | -$240K | – | 504 |
|
|
2015
Q4 | $240K | Buy |
+6,819
| New | +$240K | 0.06% | 374 |
|